切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2020, Vol. 09 ›› Issue (04) : 363 -369. doi: 10.3877/cma.j.issn.2095-3224.2020.04.007

所属专题: 文献

论著

基于权重基因共表达分析的结肠癌肝转移相关基因挖掘与验证
高博1,(), 陈卓妙语1, 王秋生1   
  1. 1. 100044 北京大学人民医院普通外科
  • 收稿日期:2020-05-22 出版日期:2020-08-25
  • 通信作者: 高博
  • 基金资助:
    国家自然科学基金青年项目(No. 81800573); 北京大学人民医院科研与发展基金青年项目(No. RDY2018-06)

The mining and verification of colorectal cancer liver metastasis-related genes based on weighted gene coexpression analysis

Bo Gao1,(), Zhuomiaoyu Chen1, Qiusheng Wang1   

  1. 1. Deapartment of General Surgery, Peking University People's Hospital, Beijing 100044, China
  • Received:2020-05-22 Published:2020-08-25
  • Corresponding author: Bo Gao
  • About author:
    Corresponding author: Gao Bo, Email:
引用本文:

高博, 陈卓妙语, 王秋生. 基于权重基因共表达分析的结肠癌肝转移相关基因挖掘与验证[J]. 中华结直肠疾病电子杂志, 2020, 09(04): 363-369.

Bo Gao, Zhuomiaoyu Chen, Qiusheng Wang. The mining and verification of colorectal cancer liver metastasis-related genes based on weighted gene coexpression analysis[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2020, 09(04): 363-369.

目的

挖掘结肠癌肝转移过程中的核心基因模块和分子靶点,并验证其对临床预后及结肠癌转移能力的影响。

方法

基于GEO数据库结肠癌肝转移测序样本,利用权重基因共表达网络分析(WGCNA)技术筛选转移相关基因模块。利用MCODE软件进一步挖掘结肠癌肝转移相关核心子模块并分析其功能。基于TCGA数据库,进行子模块基因对结肠癌预后影响的大临床样本验证。分子生物学方法验证子模块基因对结肠癌细胞系HCT116迁移和侵袭能力的影响。

结果

WGCNA分析筛选出5个基因模块,其中模块1与结肠癌肝转移关系密切。模块1共包含4个核心子模块,主要参与G蛋白偶联受体信号调节、表观遗传学调控、mRNA的剪接调节等功能。大临床样本验证发现子模块4中的FOXC1基因与结肠癌患者生存率密切相关。敲减FOXC1在HCT116细胞中的表达后,HCT116的迁移能力(t=3.123,P=0.035)和侵袭能力(t=2.936,P=0.043)受到显著抑制。

结论

本研究筛选出的结肠癌肝转移相关子模块可能具有重要的促转移作用,子模块基因FOXC1与结肠癌患者较差的生存率相关并具有促结肠癌转移能力。

Objective

To explore the core gene modules and molecular target in the process of colorectal cancer liver metastasis and to verify its impact on clinical prognosis and colorectal cancer metastasis ability.

Methods

Based on the sequencing samples of colorectal cancer liver metastasis in GEO database, WGCNA was used to screen metastasis-related gene modules. Using MCODE software to further explore the core sub-modules and analyze their function. TCGA database was used to analysis the effect of the target gene on the survival rate of colorectal cancer patients. Using molecular biology methods to verify the effect of sub-module genes on the migration and invasion of HCT116.

Results

A total of 5 modules were identified, and module 1 was closely related to colorectal cancer liver metastasis. Module 1 included 4 core sub-modules. The function of the sub-modules included adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway, epigenetic regulation, mRNA splicing and so on. Large clinical sample verification found that the FOXC1 gene in sub-module 4 was closely related to the survival rate of colon cancer patients. After knocking down the expression of FOXC1 in HCT116 cells, the migration (t=3.123, P=0.035) and invasion (t=2.936, P=0.043) of HCT116 was significantly inhibited.

Conclusion

The sub-modules related to liver metastasis of colon cancer screened in this study may have an important role in promoting metastasis. The sub-module gene FOXC1 is associated with the poor prognosis of colon cancer patients and promotes colon cancer metastasis.

图1 根据结肠癌肝转移进展过程的GSE72718数据集样本分组
图2 结肠癌肝转移相关WGCNA模块筛选。2A:结肠癌肝转移数据的WGCNA分析;2B:模块1基因表达热图,红色为高表达,绿色为低表达
图3 模块1基因的PPI互作网络
图4 模块1PPI网络中的4个子模块
图5 子模块的功能(GO)富集分析。DAVID数据库生成的GO功能条目以条形图展示。条形图的长度表示每个条目的富集分数
图6 大临床样本证实发生FOXC1差异表达的结肠癌患者预后较差
图7 FOXC1的敲减效果验证。7A:Real-time PCR结果显示FOXC1 mRNA在FOXC1-siRNA组中的表达明显低于对照组,*P<0.05;7B:Western blot结果显示FOXC1蛋白在FOXC1-siRNA组中的表达明显低于对照组
图8 Transwell实验证实FOXC1-siRNA组中HCT116细胞的迁移和侵袭能力均明显低于对照组。8A:迁移实验;8B:侵袭实验,*P<0.05
[1]
Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA: A Cancer Journal for Clinicians, 2011, 61: 69-90.
[2]
Wiseman M. The second World Cancer Research Fund/American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: A global perspective[J]. Proceedings of the Nutrition Society, 2008, 67(3): 253-256.
[3]
Pasetto LM, Jirillo A, Iadicicco G, et al. FOLFOX versus FOLFIRI: A comparison of regimens in the treatment of colorectal cancer metastases[J]. Anticancer Research, 2005, 25(1B): 563-576.
[4]
Steeg PS. Tumor metastasis: Mechanistic insights and clinical challenges[J]. Nature Medicine, 2006, 12(8): 895-904.
[5]
Gao B, Yu T, Xue D, et al. A multidimensional integration analysis reveals potential bridging targets in the process of colorectal cancer liver metastasis[J]. PLoS One, 2017, 12(6): e0178760.
[6]
Jia R, Zhao H, Jia M, et al. Identification of co-expression modules and potential biomarkers of breast cancer by WGCNA[J]. Gene, 2020, 750: 144757.
[7]
Kong J, Shen S, Zhang Z, et al. Identification of hub genes and pathways in cholangiocarcinoma by coexpression analysis[J]. Cancer Biomark, 2020, 27(4): 505-517.
[8]
Tang X, Jin R, Qu G, et al. GPR116, an adhesion G-protein-coupled receptor, promotes breast cancer metastasis via the Gαq-p63RhoGEF-Rho GTPase pathway[J]. Cancer Research, 2013, 73(20): 62066218.
[9]
Hu S, Cho EH, Lee JY. Histone Deacetylase 9: Its Role in the Pathogenesis of Diabetes and Other Chronic Diseases[J]. Diabetes & Metabolism Journal, 2020, 44(2): 234-244.
[10]
Ruland J. Colon cancer: epithelial Notch signaling recruits neutrophils to drive metastasis[J]. Cancer Cell, 2019, 36(3): 213-214.
[11]
Ramadevi S, Camacho FA, Ivy LC, et al. FOXC1 plays a crucial role in the growth of pancreatic cancer[J]. Oncogenesis, 2018, 7(7): 52.
[12]
Jeff Johnson, Michael Choi, Farnaz Dadmanesh, et al. FOXC1 identifies basal-like breast cancer in a hereditary breast cancer cohort[J]. Oncotarget, 2016, 7(46): 75729-75738.
[1] 李志伟, 向琪, 彭胜男, 郭玲, 孙贱根, 杨川. 右美托咪定与曲马多分别复合罗哌卡因在全麻下结肠癌根治术中的应用[J]. 中华普通外科学文献(电子版), 2023, 17(03): 182-185.
[2] 燕速, 霍博文, 徐惠宁. 4K荧光腹腔镜扩大右半结肠CME+D3根治术及No.206、No.204组淋巴结清扫术[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 14-14.
[3] 姚宏伟, 魏鹏宇, 高加勒, 张忠涛. 不断提高腹腔镜右半结肠癌D3根治术的规范化[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 1-4.
[4] 杜晓辉, 崔建新. 腹腔镜右半结肠癌D3根治术淋巴结清扫范围与策略[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 5-8.
[5] 周岩冰, 刘晓东. 腹腔镜右半结肠癌D3根治术消化道吻合重建方式的选择[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 9-13.
[6] 徐伯麒, 陶亮, 章帆, 毛忠琦. 结肠癌患者淋巴结转移预测模型的建立[J]. 中华普外科手术学杂志(电子版), 2023, 17(04): 393-397.
[7] 符谨诚, 李彦庆, 王亮, 邹科见. 巨大结肠脂肪瘤伴急性肠套叠一例并文献复习[J]. 中华普外科手术学杂志(电子版), 2023, 17(03): 347-348.
[8] 蓝冰, 王怀明, 王辉, 马波. 局部晚期结肠癌膀胱浸润的研究进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 505-511.
[9] 唐新, 刁德昌, 廖伟林, 林佳鑫, 汪佳豪, 李文娟, 谢嘉欣, 敖琳, 李洪明, 易小江, 卢新泉, 冯晓创. 保留神经的鞘外游离技术在腹腔镜右半结肠癌D3根治术中的近远期疗效分析:基于倾向性评分匹配的回顾性队列研究[J]. 中华结直肠疾病电子杂志, 2023, 12(05): 372-380.
[10] 陈润芝, 杨东梅, 徐慧婷. 信迪利单抗联合索凡替尼后线治疗MSS型BRAF突变的转移性结肠癌:个案报道并文献复习[J]. 中华结直肠疾病电子杂志, 2023, 12(05): 431-435.
[11] 侯文运, 刘恒昌, 窦利州, 陈海鹏, 郑朝旭, 王贵齐, 王锡山. 腹部无辅助切口内镜引导下取标本的腹腔镜辅助右半结肠癌根治术(保留回盲部)(附视频)[J]. 中华结直肠疾病电子杂志, 2023, 12(05): 436-440.
[12] 常远, 白杨, 王文秀, 孙振强, 周全博, 崔雯铭, 王玉行, 袁维堂, 胡军红. 电子结肠镜辅助经结肠取标本手术在结肠肿瘤中的临床应用分析[J]. 中华结直肠疾病电子杂志, 2023, 12(03): 196-199.
[13] 邓振汝, 林树文, 吕泽坚, 郑佳彬, 廖乾超, 冯伙伦, 吴德庆, 王俊江, 李勇. 横结肠切除与扩大结肠切除治疗横结肠癌疗效比较[J]. 中华结直肠疾病电子杂志, 2023, 12(03): 214-220.
[14] 路继永, 王帅, 张成仁, 吴德望, 杨熊飞. 腹腔镜右半结肠切除应用现状[J]. 中华结直肠疾病电子杂志, 2023, 12(03): 221-227.
[15] 李峻峰, 李军, 孙勤丰, 孙建光, 孔祥兴. 九例结肠髓样癌的临床病理特征分析[J]. 中华结直肠疾病电子杂志, 2023, 12(03): 248-252.
阅读次数
全文


摘要